Quarter 3, 2024 - Profitable Growth and Increased Market Shares
Essity has released its interim report for the third quarter of 2024, reflecting a strong performance despite challenging economic conditions worldwide. The company experienced profitable growth driven by higher volume sales and growing market shares across various sectors.
Sales and Growth Performance
During this third quarter, Essity's net sales saw a slight decline of 2.2%, totaling SEK 36,274 million, compared to the previous year's SEK 37,092 million. However, when accounting for organic growth, there was a positive increase of 1.9%. Notably, this organic growth rate revealed that volume had a significant impact, contributing 2.0%, while price/mix adjusted down slightly by 0.1%. Excluding the effects of restructuring, organic growth surged to 3.4%, highlighting resilience in the company's core operations.
Highlights of Financial Performance
In terms of profitability, Essity's earnings before interest, taxes, and amortization (EBITA) showed remarkable growth of 47%, reaching SEK 5,130 million. Furthermore, when adjusting for items affecting comparability (IAC), EBITA experienced a marginal dip of 1%, falling to SEK 5,097 million. Still, it is crucial to note when excluding foreign currency translation effects, EBITA increased by 6%. The EBITA margin, also excluding IAC, improved by 0.2 percentage points, reaching a solid 14.1%. Additionally, return on capital employed (ROCE) climbed to an impressive 17.8% from 11.7% previously, showcasing enhanced operational efficiency.
CEO's Perspective on Q3 Performance
CEO Magnus Groth commented on the quarter's achievements, noting, "The third quarter showcased strong earnings with profitable growth and record-high cash flow. Our continued emphasis on growth has enabled us to increase volumes significantly and expand our market shares globally."
Volume Growth Across Segments
Essity remains devoted to improving hygiene and health for approximately one billion individuals across 150 countries. Products from the company maintain their relevance despite economic fluctuations, supported by innovation and strategic marketing initiatives. The Health & Medical division, particularly, exhibited robust growth in Europe and Latin America, with products like TENA Pants in Incontinence Healthcare leading to higher margins and volumes, ultimately benefiting both caregivers and patients. The wound care segment also witnessed a rise in demand, favorably impacting the company's market position in this category.
Efficiency and Cost Management
The overall profitability of the Group benefited significantly from enhanced economies of scale, attributed to the rising volumes sold—an outcome of rigid price discipline despite decreased costs of goods sold. Sales prices in the third quarter were also higher in comparison to the previous quarter. Notably, Essity has successfully identified and implemented continual efficiency improvements that have generated more than SEK 1 billion in savings thus far this year. These efforts culminated in a robust quarterly result, reflecting the company's proactive approach to financial management.
Cash Flow and Share Buyback Program
One of the standout achievements during the quarter was the record-high cash flow elevated through intensified operations. As a result, Essity has been able to reduce net debt significantly. The company is consistently engaging in a share buyback program and has already repurchased around 4 million Class B shares by the end of this quarter.
Future Prospects and Commitment
Looking ahead, Essity remains committed to featuring customers and consumers as the focal point of its operations. The company plans to enhance its presence in the expanding hygiene and health markets through ongoing innovation, maintaining strong brand leadership, and driving sustainability, all while improving efficiency. A deeper insight into the company's operations and business strategies will be unveiled during the upcoming Capital Markets Day.
Frequently Asked Questions
What were the key financial results for Essity in Q3 2024?
Essity reported a net sales decrease of 2.2% to SEK 36,274 million, but organic growth rose by 1.9%. EBITA increased by 47% to SEK 5,130 million.
How did Essity address market challenges?
Despite economic hurdles, Essity expanded its customer base through innovation and efficiency improvements, leading to increased market shares.
What sectors showed growth for Essity?
Significant growth was seen in Health & Medical, particularly in Europe and Latin America, while the Consumer Goods sector also contributed positively.
What measures did Essity take for cost savings?
Essity achieved over SEK 1 billion in savings from efficiency enhancements and maintained rigorous price discipline in its operations.
What is on the horizon for Essity?
Essity aims to continue expanding its leadership in hygiene and health markets through innovative solutions and sustainable practices moving forward.
